Synergistic antitumor efficacy by combining adriamycin with recombinant human endostatin in an osteosarcoma model

In the last 15 years, chemotherapy-based therapeutic regimens for the treatment of osteosarcoma have failed to demonstrate improved survival rates. Novel approaches, including targeted therapy and antiangiogenic therapy, may provide new methods for the treatment of osteosarcoma, one of the most dead...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Xu, Hairong, Niu, Xiaohui, Zhang, Qing, Hao, Lin, Ding, Yi, Liu, Weifeng, Yao, Lu
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: D.A. Spandidos 2011
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3408098/
https://ncbi.nlm.nih.gov/pubmed/22866125
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2011.334
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak